Clinical trial

Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis

NCT06501391

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-07-01

PhasePHASE2

Study timeline

Study start (actual)2024-07-01Date precision: day

Registry last updated2024-08-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLC Stage IVunresolved

Brain Metastasesunresolved

Interventions

PD-L1/PD-1 inhibitor and chemotherapyDRUG

SRT or WBRTRADIATION

Sponsors & collaborators

Fudan Universitylead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06501391 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.